Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Elsbernd Brian Create: Alert

All | News | Filings
Date FiledTypeDescription
03/22/2023 4 Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Sold 50,000 shares @ $16.069, valued at $803.5k
Exercised 50,000 options to buy @ $1.13, valued at $56.5k
12/29/2022 4 Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Granted 69,000 options to buy @ $18.59, valued at $1.3M
Granted 20,000 restricted stock units @ $0
12/08/2022 4 Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Exercised 14,667 restricted stock units @ $0
11/15/2022 4 Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Sold 14,666 shares @ $16.235, valued at $238.1k
Exercised 65,000 options to buy @ $1.85, valued at $120.3k
Exercised 40,000 options to buy @ $0.79, valued at $31.6k
02/16/2022 4 Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Granted 29,000 restricted stock units @ $0
12/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2020 4 Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Exercised 14,666 shares @ $0
Granted 14,666 restricted stock units @ $0
12/04/2019 4 Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns: Granted 132,000 options to buy @ $4.64, valued at $612.5k
Granted 44,000 restricted stock units @ $0
01/04/2019 3 Elsbernd Brian (Chief Compliance/Legal Officer) has filed a Form 3 on CATALYST PHARMACEUTICALS, INC.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy